MNDL Bio

MNDL Bio is an Israeli synthetic-biology startup using AI and biophysical modeling to optimize DNA constructs for higher-yield recombinant protein production.

Health Tech & Life Sciences
Active
Pre-Seed Tel Aviv-Yafo, Israel Founded 2023
Last updated 2026-07-26
Total raised
$2.1M
Last: Undisclosed Round 2024-01
Stage
Pre-Seed
Founded
2023
Headcount
8
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

MNDL Bio is an Israeli synthetic-biology startup that leverages AI and biophysical modeling to optimize DNA constructs for higher-yield recombinant protein production. The company's platform aims to revolutionize food and biotech production by offering a computational platform that transitions from traditional trial-and-error methods to a precise engineering approach. This technology streamlines workflows, accelerates timelines, boosts yields, and dramatically reduces costs in recombinant protein development. MNDL Bio's core gene expression optimization technology is a mature and validated solution, developed over 15 years by Prof. Tamir Tuller and his lab. It is currently available as a service to customers, and the company is developing a SaaS platform to expand accessibility and streamline delivery. The first version of this platform is scheduled for release in early 2025.

Funding history · 2 rounds · $2.1M total

2023-12
Pre-Seed $2.0M
★ Earth & Beyond VenturesCPT Capital
2023-06
Grant $100K

Headcount over time

From 6 (2023-07) to 10 (2026-03) · +4 (+67%) · 7 points · source: Finder history + radar grounding
110 2023-07 2026-03

Q&A

What is MNDL Bio's primary focus?
MNDL Bio is an Israeli synthetic-biology startup that uses AI and biophysical modeling to optimize DNA constructs for higher-yield recombinant protein production.
When was MNDL Bio founded?
MNDL Bio was founded in June 2023.
How much funding has MNDL Bio raised to date?
MNDL Bio has raised a total of $2.1 million.
Which investors participated in MNDL Bio's Pre-Seed round in July 2024?
MNDL Bio's Pre-Seed round in July 2024 included investments from Earth & Beyond Ventures.
What is the status of MNDL Bio's SaaS platform?
MNDL Bio's SaaS platform, which will expand accessibility and streamline delivery of its gene expression optimization technology, is scheduled for release in early 2025.
What award did MNDL Bio win in March 2025?
In March 2025, MNDL Bio won an award for the most innovative biotech solution in the Middle East.
Who are the co-founders of MNDL Bio?
The co-founders of MNDL Bio are Steve Grun (CEO), Prof. Tamir Tuller (CSO), and Eran Miller (CBO).

Team · 3

Steve Grun
Founder · CEO and Co-Founder
Prof. Tamir Tuller
Founder · CSO and Co-Founder
Eran Miller
Founder · CBO and Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringClimate TechClean Industry Tech Sustainable Materials & Circularity
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsIndustrial ManufacturingProcess IndustriesPlasticsChemicals & PetrochemicalsEnergy, Utilities & Waste ManagementNew FuelsBiofuelsWaste Treatment, Environmental Services & RecyclingAgriculture & FoodLivestock
Business model
B2B

Highlights

Climate Tech1 PatentsVerified

Tags

climate-techbiotechnologygene-editingbiofuelmaterials
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemndl.bio
LinkedInlinkedin.com/company/96395398

Identifiers & details

Legal nameMNDL BIO LTD
Founded2023-6
Employees (exact)8

Radar intelligence

Web history (Wayback)

Domainmndl.bio

Certificate / subdomain footprint

Subdomains5

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516889235
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2023-11-12
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Active charges / liens0
Registry events3 — violation (1), shares_capital (1), people (1)
Registered addressויינשל 19 תל אביב - יפו

Recent registry events

DateEvent
2026-06-25עדכון הפרה
2025-07-23שינוי בהרכב הון - מניות-הפחתת הון מוקצה
2025-08-17עדכון דירקטורים-הוספת דירקטור